• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

76.75 -1.08 (-1.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 403,530
Open 77.32
Bid (Size) 75.50 (500)
Ask (Size) 85.00 (200)
Prev. Close 77.83
Today's Range 75.30 - 77.51
52wk Range 32.82 - 82.94
Shares Outstanding 71,726,685
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kiniksa Highlights ARCALYST Growth as KPL-387 Advances Into Phase 3 ↗
August 14, 2026
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) said its commercialized recurrent pericarditis treatment ARCALYST continues to grow, while the company has begun a pivotal Phase 3 study of follow-on... 
Via MarketBeat
Which stocks are gapping on Tuesday? ↗
July 28, 2026
Via Chartmill

Performance

YTD
+82.7%
+82.7%
1 Month
+24.4%
+24.4%
3 Month
+35.8%
+35.8%
6 Month
+69.2%
+69.2%
1 Year
+130.6%
+130.6%

More News

Read More
News headline image
Kiniksa Pharmaceuticals International Q2 Earnings Call Highlights ↗
July 28, 2026
Via MarketBeat
Topics Artificial Intelligence Earnings
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Growth Stock Surges on Revenue Beat and Raised Guidance ↗
July 28, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA): A High-Growth Stock with Strong Technical Setup ↗
July 27, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA): A High Growth Momentum Stock With a Breakout Setup ↗
July 24, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Qualifies as an Affordable Growth Stock With Strong Revenue and Earnings Momentum ↗
July 21, 2026
Via Chartmill
Kiniksa Pharmaceuticals International Plc (NASDAQ:KNSA) Presents a Compelling GARP Opportunity ↗
June 24, 2026
Via Chartmill
News headline image
Kiniksa (KNSA) Q1 2026 Earnings Transcript ↗
June 01, 2026
Via The Motley Fool
Topics Artificial Intelligence
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Screens as Affordable Growth ↗
May 29, 2026
Via Chartmill
Kiniksa Pharmaceuticals (KNSA) Shows Explosive Potential with Perfect Minervini Trend Template and 460% EPS Growth ↗
May 25, 2026
Via Chartmill
News headline image
Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally ↗
May 23, 2026
Via MarketBeat
News headline image
Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today ↗
April 28, 2026
Via The Motley Fool
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Surges on Q1 Earnings Beat and Raised ARCALYST Guidance ↗
April 28, 2026
Via Chartmill
Topics Earnings
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Surfaces as a GARP Opportunity with a Growth Rating of 8 ↗
April 25, 2026
Via Chartmill
Gapping stocks in Tuesday's session ↗
April 28, 2026
Via Chartmill
News headline image
What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge ↗
April 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Kiniksa Pharmaceuticals (KNSA) Shows High Growth Momentum and Technical Breakout Potential ↗
April 14, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Fits the Minervini Trend Template with High-Growth Momentum ↗
April 03, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Presents a Compelling Growth and Technical Setup ↗
March 30, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Presents a High-Growth Momentum Setup ↗
March 23, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top GARP Investment ↗
March 20, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shows Strong Growth and Bullish Chart Setup ↗
March 05, 2026
Via Chartmill
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Shows High-Growth Momentum and Strong Technical Setup ↗
March 02, 2026
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA): A Prime Example of Affordable Growth (GARP) Investing ↗
February 27, 2026
Via Chartmill

Frequently Asked Questions

Is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares publicly traded?
Yes, Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is publicly traded.
What exchange does Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trade on?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
What is the current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 76.75
When was Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares last traded?
The last trade of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares was at 08/14/26 04:00 PM ET
What is the market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 5.51B
How many shares of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares are outstanding?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap